Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
19 10 2021
Historique:
entrez: 8 11 2021
pubmed: 9 11 2021
medline: 6 4 2022
Statut: epublish

Résumé

During activation, the metabolism of T cells adapts to changes that impact their fate. An increase in mitochondrial oxidative phosphorylation is indispensable for T cell activation, and the survival of memory T cells is dependent on mitochondrial remodeling. Consequently, this affects the long-term clinical outcome of cancer immunotherapies. Changes in T cell quality are often studied by flow cytometry using well-known surface markers and not directly by their metabolic state. This is an optimized protocol for measuring real-time mitochondrial respiration of primary human T cells using an Extracellular Flux Analyzer and the cytokines IL-2 and IL-15, which differently affect T cell metabolism. It is shown that the metabolic state of T cells can clearly be distinguished by measuring the oxygen consumption when inhibiting key complexes in the metabolic pathway and that the accuracy of these measurements is highly dependent on optimal inhibitor concentration and inhibitor injection strategy. This standardized protocol will help implement mitochondrial respiration as a standard for T cell fitness in monitoring and studying cancer immunotherapies.

Identifiants

pubmed: 34747403
doi: 10.3791/62984
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Kasper Mølgaard (K)

National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev.

Anne Rahbech (A)

National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev.

Özcan Met (Ö)

National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev.

Inge Marie Svane (IM)

National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev.

Per Thor Straten (P)

National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev; Department of Immunology and Microbiology, Inflammation and Cancer Group, University of Copenhagen.

Claus Desler (C)

Department of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen.

Marlies J W Peeters (MJW)

National Center for Cancer Immune Therapy, Department of Oncology, University Hospital Herlev; marlies.peeters@regionh.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH